BUFRvsGSKH
FT CBOE VEST FUND OF BUFFER ETFS against GSK plc ADRhedged — the fee, the flows, the book, and a year head-to-head.
Head to head
| BUFR | GSKH | |
|---|---|---|
| Expense ratio | 0.10% | 0.17% |
| Assets | $5.1B | $786,000 |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | — |
| Return, YTD | +7.6% | +6.5% |
| Return, 1 year | — | +6.8% |
| Avg daily volume | 1.5M | 404 |
| Holdings | 12 | 0 |
| Listed | Oct 15, 2023 | Jan 3, 2025 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS